Strs Ohio Invests $413,000 in Accendra Health, Inc. $ACH

Strs Ohio purchased a new position in Accendra Health, Inc. (NYSE:ACH) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 181,200 shares of the company’s stock, valued at approximately $413,000. Strs Ohio owned approximately 0.24% of Accendra Health at the end of the most recent reporting period.

Separately, Keybank National Association OH purchased a new stake in shares of Accendra Health during the first quarter valued at approximately $46,000.

Accendra Health Trading Up 4.2%

ACH opened at $3.44 on Friday. The stock has a market capitalization of $263.44 million, a price-to-earnings ratio of -0.24, a P/E/G ratio of 5.09 and a beta of 1.58. Accendra Health, Inc. has a 12 month low of $1.84 and a 12 month high of $8.40. The stock has a 50-day moving average of $3.13.

Accendra Health (NYSE:ACH) last issued its quarterly earnings data on Monday, May 11th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.06) by $0.02. The business had revenue of $627.78 million for the quarter. Accendra Health had a negative return on equity of 13.18% and a negative net margin of 39.84%. Analysts predict that Accendra Health, Inc. will post 0.31 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages have commented on ACH. UBS Group increased their target price on Accendra Health from $3.00 to $4.50 and gave the company a “neutral” rating in a research note on Tuesday, May 12th. Weiss Ratings cut shares of Accendra Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, July 1st. Citigroup lifted their target price on Accendra Health from $3.25 to $5.00 and gave the company a “buy” rating in a research note on Tuesday, May 12th. Robert W. Baird lifted their price objective on Accendra Health from $5.00 to $6.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 12th. Finally, Zacks Research upgraded Accendra Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 21st. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $5.17.

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.